APA (7th ed.) Citation

Blair, G. W., Appleton, J. P., Law, Z. K., Doubal, F., Flaherty, K., Dooley, R., . . . Wardlaw, J. M. (2018). Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mononitrate and cilostazol, separately and in combination. Sage.

Chicago Style (17th ed.) Citation

Blair, Gordon W., et al. Preventing Cognitive Decline and Dementia from Cerebral Small Vessel Disease: The LACI-1 Trial. Protocol and Statistical Analysis Plan of a Phase IIa Dose Escalation Trial Testing Tolerability, Safety and Effect on Intermediary Endpoints of Isosorbide Mononitrate and Cilostazol, Separately and in Combination. Sage, 2018.

MLA (9th ed.) Citation

Blair, Gordon W., et al. Preventing Cognitive Decline and Dementia from Cerebral Small Vessel Disease: The LACI-1 Trial. Protocol and Statistical Analysis Plan of a Phase IIa Dose Escalation Trial Testing Tolerability, Safety and Effect on Intermediary Endpoints of Isosorbide Mononitrate and Cilostazol, Separately and in Combination. Sage, 2018.